CCL2 and neoplasm: For example, CCL2 and IL-6 were found to contribute to the survival of CD11b+ myeloid monocytes recruited to the tumor microenvironment and skew the phenotype toward tumor-promoting CD14+/CD206+ M2-type macrophages [62].